In Nevada, both the number of heat-related deaths and heat-related worker complaints more than doubled from 2022 to 2023, signaling a scorching future.
Politics and Government
Friday’s statement by the Israeli military suggested its forces have been operating in most parts of the city.
Biden added that Hamas is “no longer capable” of carrying out another large-scale attack on Israel as he urged Israelis and Hamas to come to a deal to release the remaining hostages for an extended cease-fire.
A senior member of the House Aviation subcommittee, Rep. Dina Titus backed the FAA Reauthorization Act, which will provide funding for general aviation airports.
The Las Vegas Review-Journal owner and majority shareholder of Las Vegas Sands Corp. will be a major backer of the Preserve America super PAC.
Oral arguments at the Supreme Court on Wednesday represent the best opportunity leaders on the right have had in decades to gut the landmark 1973 Roe v. Wade decision.
Mark Meadows, Donald Trump’s former chief of staff, is cooperating with a House panel investigating the Jan. 6 Capitol insurrection and providing some documents, putting off for now the panel’s threat to hold him in contempt, the committee’s chairman said Tuesday.
Both sides are telling the Supreme Court there’s no middle ground in Wednesday’s showdown over abortion. The justices can either reaffirm the constitutional right to or wipe it away.
House Democrats wrapped up details and voted Friday to pass a massive social spending package that would be largely paid for by tax increases on the wealthy and corporations.
House approval — which Minority Leader Kevin McCarthy held up with an hours-long speech — was still expected on a near party-line vote
Nevada is expected to get $4 billion to fund infrastructure projects in the legislation.
The new requirements, first previewed by President Joe Biden in September, will apply to about 84 million workers at medium and large businesses, including many Nevada businesses.
U.S. regulators are delaying their decision on Moderna’s COVID-19 vaccine for 12- to 17-year-olds while they study the rare risk of heart inflammation, the company said Sunday.